Leverage for Chiron's vaccines

Concurrently with the merger agreement between Univax Biologics Inc. and North American Biologicals Inc., UNVX announced it was adding to its pipeline via a collaborative agreement with Chiron Corp. to develop immunotherapeutics based on vaccines in development at Chiron Biocine.

Under the agreement in principle, UNVX has exclusive worldwide rights to Chiron Biocine's vaccines for use as immunizing agents to